[PAGID] IVIG and aseptic meningitis
Lisa Kobrynski, MD, MPH
lkobryn at emory.edu
Fri Dec 7 14:21:31 EST 2007
We have used all the afore mentioned strategies for dealing with the headaches.
Somethings seem to work better than others. We have used 1 or 2 doses of
Decadron 12-48 hours post infusion and that seems to work for the majority of
patients.
It seems as if we all have multiple patients who experience post-infusion
headache and have tried a variety of therapies for this. I don't know if this
is a true epi-phenomenon or not, but it does seem to be a more frequent problem
in our clinic than 10 years ago. Does anyone else have that impression? Is
there any data on frequency/prevalence of this side effect and the effect of
various therapies? If not, it might be helpful for the community at large to
put together a description of our collective experience.
Just a thought.
Lisa
Lisa Kobrynski, MD, MPH
Assistant Professor of Pediatrics
Division of Allergy and Immunology
Emory University
404-727-3575
404-727-5045 (fax)
Quoting "Berger, Melvin" <Melvin.Berger at UHhospitals.org>:
> I agree with Anita- dividing the dose and giving smaller increments more
> frequently certainly might help, and sub-cu usually facilitates that. If
> that is not feasible, we often try to prophylax delayed migraines with
> prednisone at the end of the infusion, 24 and 48 hrs later for the next
> couple of infusions, and/or periactin the morning after the infusion and the
> next morning. Often after 2 or 3 infusions, or with a different product,
> severe headaches/migraines remit, but some people continue to have them like
> clockwork 48-72 hours after the infusion. It has never been clear to me
> whether post infusion migraine and aseptic meningitis are part of a spectrum
> or have different pathophysiologies.
>
> Melvin Berger, M.D., Ph.D.
> Professor of Pediatrics and Pathology
> Case Western Reserve University
> phone 216 844 3237
>
> Director, Jeffrey Modell Center for Primary Immune Deficiencies
> Division of Allergy-Immunology
> Rainbow, Babies and Children's Hospital
> University Hospitals of Cleveland
> RB&C Rm 504, MS 6008B
> 11100 Euclid Ave.
> Cleveland, OH 44106
>
> ________________________________
>
> From: pagid-bounces at list.clinimmsoc.org on behalf of Anita Gewurz
> Sent: Wed 12/5/2007 12:55 PM
> To: pagid at list.clinimmsoc.org
> Subject: Re: [PAGID] IVIG and aseptic meningitis
>
>
> Chris,
>
>
> SC gammaglobulin (SCGG) would avoid the problem. If you have a young child
> on SCGG who could show your patient how it works, he might be less fearful of
> it. Any local discomfort with initial infusions can be minimized with
> topical lidocaine and lower starting doses. As Mel Berger and others will
> tell you, the infusion can be completed while the patient watches a video,
> does homework or sleeps and can go with him on vacation trips.
> Quality-of-life is better for the whole family and so are trough IgGs.
>
> Good luck!
>
> Anita
>
> Anita Gewurz MD <agewurz at rush.edu>
> Section of Allergy/Immunology
> Department of
> Immunology/Microbiology
> Rush University Medical Center
> 1725 W Harrison - 117
> Chicago IL 60612
> TEL (312) 942-6296
> VM (312) 942-4912
> FAX (312) 563-2201
> PAGER/CELL (847) 224-8550
>
>
>
>
> On Dec 5, 2007, at 9:21 AM, Chris Seroogy wrote:
>
>
> Dear Colleagues,
>
> I have a question about management of aseptic meningitis and IVIG.
>
> We have a 5 y/o with chemotherapy-induced immunodeficiency who meets
> criteria for immunoglobulin replacement. He just had his first infusion
> (400mg/kg gammagard S/D) which went well, but 48 hours later developed
> severe headache and stiff neck. I did not evaluate him, but the heme/onc
> colleagues felt he had aseptic meningitis and this resolved with pain
> management.
>
> My question is what has worked for individuals to prevent/prophylaxis this
> side effect? He needs the product and I am told subcutaneous is not an
> option since he will pull out the tubing and it would be too much of a
> time
> commitment for the family. Thank you for any input! Regards, Chris
>
>
>
>
>
>
>
> Visit us at www.UHhospitals.org.
>
> The enclosed information is STRICTLY CONFIDENTIAL and is intended for the use
> of the addressee only. University Hospitals and its affiliates disclaim any
> responsibility for unauthorized disclosure of this information to anyone
> other than the addressee.
>
> Federal and Ohio law protect patient medical information, including
> psychiatric_disorders, (H.I.V) test results, A.I.Ds-related conditions,
> alcohol, and/or drug_dependence or abuse disclosed in this email. Federal
> regulation (42 CFR Part 2) and Ohio Revised Code section 5122.31 and 3701.243
> prohibit disclosure of this information without the specific written consent
> of the person to whom it pertains, or as otherwise permitted by law.
More information about the PAGID
mailing list